J. Straus

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer

D. McNeel, J. Eickhoff, Glenn Liu, 2018, Oncotarget.

Semen AMACR protein as a novel method for detecting prostate cancer.

M. Ritter, Wei Huang, D. Jarrard, 2018, Urologic oncology.

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

D. McNeel, G. Wilding, J. Eickhoff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

D. McNeel, G. Wilding, J. Eickhoff, 2008, Clinical Cancer Research.

A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.

D. McNeel, G. Wilding, J. Eickhoff, 2005, Clinical genitourinary cancer.

Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.

R. Jeraj, S. Perlman, Glenn Liu, 2015, Clinical genitourinary cancer.

Randomized , Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients withMetastatic , Androgen-Independent Prostate Cancer

G. Wilding, J. Eickhoff, S. Attia, 2008 .

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

D. McNeel, G. Wilding, J. Eickhoff, 2008, Clinical Cancer Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.